Discovery and validation of DNA hypomethylation biomarkers for liver cancer using HRM-specific probes.
Poor prognosis of hepatocellular carcinoma (HCC) associated with late diagnosis necessitates the development of early diagnostic biomarkers. We have previously delineated the landscape of DNA methylation in HCC patients unraveling the importance of promoter hypomethylation in activation of cancer- a...
Guardado en:
Autores principales: | Barbara Stefanska, Aurelie Bouzelmat, Jian Huang, Matthew Suderman, Michael Hallett, Ze-Guang Han, Mamun Al-Mahtab, Sheikh Mohammad Fazle Akbar, Wasif Ali Khan, Rubhana Raqib, Moshe Szyf |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4ebfda4443a54d268ec3e4fa2c648e54 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Innovative HRM. A Review of the Literature
por: Koster,Ferry
Publicado: (2019) -
The development of unlabeled probes-high resolution melting (UP-HRM) marker on SAD, IAA27 and ACC genes of oil palm
por: TENGKU IMAM SAPUTRA, et al.
Publicado: (2021) -
Sustained Antiviral and Liver Protection by a Nasal Therapeutic Vaccine (NASVAC, Containing Both HBsAg and HBcAg) in Patients with Chronic Hepatitis B: 2-Year Follow-Up of Phase III Clinical Trial
por: Sheikh Mohammad Fazle Akbar, et al.
Publicado: (2021) -
Cultural Conditions of HRM – 3D Model
por: Halina Sobocka-Szczapa
Publicado: (2020) -
Transcriptional overlap links DNA hypomethylation with DNA hypermethylation at adjacent promoters in cancer
por: Jean S. Fain, et al.
Publicado: (2021)